Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer

Recruiting now · Phase 2

Conditions studied: Non-Small Cell Lung Cancer

In brief

The researchers are doing this study to test the ability of a new technology called breathprinting, or electronic nose (E-Nose), to measure changes in certain chemicals in the breath before and after standard neoadjuvant therapy in people with NSCLC.

Key facts

Study ID
NCT07218601
Run by
Memorial Sloan Kettering Cancer Center
People needed
60
Starts
2025-10-10
Expected to finish
2027-10-01
Last updated by the study team
2026-03-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.